Domo Customer Unilever Wins the Ventana Research Digital Leadership Award

Domo Customer Unilever Wins the Ventana Research Digital Leadership Award

Unilever’s Alessandro Ventura Recognized for his Leadership in the Application of Analytics with Domo to Support Company’s Nationwide Pandemic Relief Effort

SILICON SLOPES, Utah–(BUSINESS WIRE)–Domo (Nasdaq: DOMO) today announced that its customer Unilever, the multinational consumer goods company, and Alessandro Ventura, CIO and Head UniOps Market Operations of Unilever North America, was named the winner with Domo of Ventana Research’s prestigious Digital Leadership Award in Analytics. This update follows Domo’s announcement of the two companies being named Finalist for the award.

Ventana Research’s Digital Leadership Awards showcase the leadership and use of business applications or technology that contribute significantly to improved efficiency, productivity and performance. In the category of Analytics, the winners are the company and technology provider that best exemplifies leadership in any use or application of analytics across business and/or IT.

In a long and rich tradition as a pioneer and innovator of consumer goods, Unilever understood the unique opportunity to create positive change during the global pandemic. Unilever launched the United for America initiative in March 2020 that culminated in a National Day of Service in May. The effort produced $25 million in goods and services that were donated to help the hardest-hit communities by COVID-19 recover, rebuild and reimagine their futures.

Domo supported this effort by building Unilever’s data management system for United for America on Domo’s modern analytics and BI platform. With Domo, the Unilever team created and extended multiple live data insights across the United for America website, giving their project partners and stakeholders real-time information into how resources were benefiting communities. This real-time data helped keep the project’s nearly 100 partners engaged in the ongoing program and working towards its success. It also provided internal Unilever stakeholders such as brand managers, the ability to see how their specific products were being distributed to relief efforts across the country. The system integrated Domo’s coronavirus tracker with aggregated and interactive data, which was crucial in determining the communities of highest COVID-19 impact at any given moment.

“The global pandemic has highlighted the need for real-time actionable data across all sectors of the economy, including philanthropic efforts like Unilever’s United for America initiative. Domo excels in moments like these, when widespread access to a broad, and often new, set of data sources, can provide the intelligence needed to accelerate an initiative’s success,” said Josh James, founder and CEO, Domo. “Congratulations to Ale and his team for this well-deserved win; it is an honor for Domo have played a part in putting data to work for this very important program.”

“The analytics supporting Unilever’s United for America program demonstrated the value of shared real-time insights getting resources to the places they were needed most,” said David Menninger, SVP and research director, Ventana Research. “Domo’s cloud-based system enabled stakeholders in various organizations and various locations to access and share the same set of information helping the initiative accomplish its objectives. Congratulations to all involved.”

To learn more about the Unilever United for America initiative, visit: https://www.weareunitedforamerica.com/

To access Domo’s free COVID-19 tracker, visit https://www.domo.com/coronavirus-tracking

About Domo

Domo is the Business Cloud, empowering organizations of all sizes with BI leverage at cloud scale, in record time. With Domo, BI-critical processes that took weeks, months or more can now be done on-the-fly, in minutes or seconds, at unbelievable scale. For more information about how Domo (Nasdaq: DOMO) helps its customers go fast, go big and go bold, visit www.domo.com. You can also follow Domo on Twitter, Facebook and LinkedIn.

Domo, Domo Business Cloud and Domo is the Business Cloud are registered trademarks of Domo, Inc.

Cynthia Cowen

[email protected]

KEYWORDS: Utah United States North America

INDUSTRY KEYWORDS: Software Technology Internet Data Management

MEDIA:

Logo
Logo

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020

TUSTIN, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the second quarter of fiscal year 2021 on December 2, 2020 after market close and will host a conference call and webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time). Members of Avid’s senior management will discuss financial results for the second quarter and review recent corporate developments.

To listen to the live webcast, or access the archived webcast, please visit: http://ir.avidbio.com/investor-events.

To listen to the conference call, please dial (877) 312-5443 or (253) 237-1126 and request the Avid Bioservices call.

About Avid
Bioservices
, Inc.

Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 27 years of experience producing monoclonal antibodies and recombinant proteins, Avid’s services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com



Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
[email protected]

Tim Brons (Media)
Vida Strategic Partners 
415-675-7402
[email protected]

E*TRADE Politics & Portfolios Study Reveals Economic and Market Views Among Republican and Democrat Investors Post Election

E*TRADE Politics & Portfolios Study Reveals Economic and Market Views Among Republican and Democrat Investors Post Election

While Republicans and Democrats diverge on economic outlook, a significant portion of both parties is not bullish on the market

ARLINGTON, Va.–(BUSINESS WIRE)–
E*TRADE Financial, LLC today announced results from its Politics & Portfolios study on voting investor sentiment after the presidential election:

  • Both parties muted on market performance. While the majority of Democrats skew more positive, 44% are either bearish or believe the market will stay the same as a result of the election. Among Republicans, 62% are bearish or believe the market will remain flat.
  • Republicans brace for volatility. Republicans (64%) are significantly more likely than Democrats (47%) to expect more market volatility after the election.
  • Both parties are eager to revisit portfolios. Roughly three out of five of both Republicans (61%) and Democrats (58%) plan to make changes to their portfolio after the election.
  • Democrats see shorter runway to recovery. More than three out of four Democrats (77%) believe election results will accelerate an economic recovery. On the other hand, half of Republicans (51%) expect the economy to decelerate.

“Traditionally there tends to be more stability in the markets after an election—but this year was anything but traditional,” said Mike Loewengart, Managing Director, Investment Strategy at E*TRADE Financial. “Investors continue to contend with big unknowns—the pending stimulus bill, the velocity of the ongoing pandemic, and even a contested election outcome. All these factors could remain significant drivers of volatility. While it may be tempting to play with portfolio allocations right now, it bears repeating: When it comes to politics and investing, try to tune out the noise. Keep financial decisions mapped to your personal timeline, goals, and risk tolerance.”

The survey also explored views on sector opportunities as a result of the presidential election:

  • Health care:Though President-elect Biden advocated for the expansion of the Affordable Care Act, a split Congress could pose headwinds for sweeping reform. That said, 68% of the total surveyed see potential in the health care sector. Amid significant strides on the vaccine front, intrepid investors could be on the hunt for growth potential.
  • Energy: Since a sustainable economy was another top campaign point from President-elect Biden, 40% of surveyed respondents believe the sector could stand to benefit especially in green alternatives.
  • Information technology: The red-hot tech sector ranked third among investors. While the stay-at-home economy boosted tech names, almost 40% of surveyed investors think there’s more room to run as states reinstitute lockdowns. This sector tends to be highly scrutinized in the Beltway and a divided Congress could keep significant changes in regulation at bay.

E*TRADE aims to enhance the financial independence of traders and investors through a powerful digital offering and professional guidance. To learn more about E*TRADE’s trading and investing platforms and tools, visit etrade.com.

For useful trading and investing insights from E*TRADE, follow the company on Twitter, @ETRADE.

To learn more about the findings, view the Politics & Portfolios infographic.

About the Survey

This wave of the survey was conducted from November 9 to November 17 of 2020 among an online US sample of 789 self-directed active voting investors who manage at least $10,000 in an online brokerage account. The survey has a margin of error of ±3.50 percent at the 95 percent confidence level. It was fielded and administered by Dynata®. The panel is 50% Republican and 50% Democratic, as well as 40% female and 60% male, with a distribution across online brokerages, geographic regions, and age bands.

Referenced Data

As a result of the presidential election, what is your outlook on the US financial markets?

 

Total

Democratic

Republican

More bullish

46%

 

56%

 

38%

Much more bullish

15%

 

18%

 

13%

Somewhat more bullish

31%

 

38%

 

25%

No change

26%

 

27%

 

24%

Somewhat more bearish

19%

 

14%

 

22%

Much more bearish

9%

 

3%

 

16%

More bearish

28%

 

17%

 

38%

As a result of the US presidential election, do you think market volatility will…

 

Total

 

Democratic

 

Republican

Increase

55%

 

47%

 

64%

Greatly increase

22%

 

19%

 

25%

Somewhat increase

33%

 

28%

 

39%

Stay the same

26%

 

29%

 

22%

Somewhat decrease

16%

 

21%

 

10%

Greatly decrease

3%

 

3%

 

4%

Decrease

19%

 

24%

 

14%

As a result of the presidential election, which of the following strategies are you planning to deploy?

 

Total

 

Democratic

 

Republican

Move out of current positions and into cash

21%

 

19%

 

23%

Move out of cash and into new positions

18%

 

21%

 

15%

Change the allocations in my portfolio

20%

 

18%

 

23%

Make no changes to my portfolio

39%

 

41%

 

37%

Other

2%

 

1%

 

2%

Do you think the results of the election will ____ economic recovery?

 

Total

 

Democratic

 

Republican

Accelerate (Top 2 Box)

55%

 

77%

 

33%

Greatly accelerate

23%

 

33%

 

14%

Somewhat accelerate

32%

 

44%

 

19%

Neither accelerate or decelerate

16%

 

16%

 

16%

Somewhat decelerate

15%

 

5%

 

25%

Greatly decelerate

14%

 

2%

 

26%

Decelerate (Bottom 2 Box)

29%

 

7%

 

51%

Which sectors do you think will benefit most from the presidential election? (Top three)

 

Total

 

Democratic

 

Republican

Health care

68%

 

74%

 

61%

Energy

40%

 

44%

 

37%

Information Technology

39%

 

38%

 

41%

Financials

30%

 

35%

 

26%

Consumer Staples

26%

 

28%

 

25%

Consumer Discretionary

23%

 

23%

 

23%

Communication Services

19%

 

15%

 

25%

Industrials

16%

 

15%

 

16%

Utilities

16%

 

9%

 

22%

Materials

14%

 

11%

 

17%

Real estate

9%

 

9%

 

8%

About E*TRADE Financial and Important Notices

E*TRADE Financial and its subsidiaries provide financial services including brokerage and banking products and services to retail customers. Securities products and services are offered by E*TRADE Securities LLC (Member FINRA/SIPC). Commodity futures and options on futures products and services are offered by E*TRADE Futures LLC (Member NFA). Managed Account Solutions are offered through E*TRADE Capital Management, LLC, a Registered Investment Adviser. Bank products and services are offered by E*TRADE Bank, and RIA custody solutions are offered by E*TRADE Savings Bank, both of which are national federal savings banks (Members FDIC). More information is available at www.etrade.com.

The information provided herein is for general informational purposes only and should not be considered investment advice. Past performance does not guarantee future results.

E*TRADE Financial, E*TRADE, and the E*TRADE logo are trademarks or registered trademarks of E*TRADE Financial, LLC. ETFC-G

© 2020 E*TRADE Financial, LLC, a business of Morgan Stanley. All rights reserved.

E*TRADE Financial engages Dynata to program, field, and tabulate the study. Dynata provides digital research data and has locations in the Americas, Europe, the Middle East and Asia-Pacific. E*TRADE Financial and Dynata are separate and unaffiliated companies. For more information, please go to www.dynata.com.

E*TRADE Media Relations

646-521-4418

[email protected]

KEYWORDS: Virginia United States North America

INDUSTRY KEYWORDS: Professional Services White House/Federal Government Public Policy/Government Finance Banking Elections/Campaigns

MEDIA:

Logo
Logo

Flex Appoints John D. Harris II to its Board of Directors

Flex Appoints John D. Harris II to its Board of Directors

SAN JOSE, Calif.–(BUSINESS WIRE)–
Flex (NASDAQ: FLEX) today announced that John D. Harris II, a seasoned executive leader, has joined the Company’s Board of Directors, effective November 23, 2020.

Mr. Harris has over 30 years of technology, non-profit and business board experience, and most recently served as vice president of Business Development for Raytheon Company and chief executive officer of Raytheon International, Inc. In this role, Mr. Harris was responsible for worldwide sales and marketing, international business and government relations operations functions. He was also responsible for developing and leading the execution of Raytheon’s global business strategy.

Mr. Harris joined Raytheon in 1983. Throughout his career, he held positions of increasing responsibility, including vice president of Operations and Contracts for Raytheon’s former Electronic Systems business, vice president of Contracts for the company’s government and defense businesses, and vice president of Contracts and Supply Chain for Raytheon Company. In 2010, he was named president of Raytheon Technical Services Company (RTSC). Mr. Harris also served as general manager of Raytheon’s Intelligence, Information and Services business, where he was responsible for the consolidation of the former RTSC with Raytheon’s Intelligence and Information Systems business.

Mr. Harris served on the RTCA NextGen Advisory Committee, the Board of the USO of Metropolitan Washington, D.C., the National Advisory Council on Minority Business Enterprise with the U.S. Department of Commerce, and was a member of the Council of Trustees for the Association of the United States Army. He served as Raytheon’s Executive Diversity Champion in 2007-2008, leading the Executive Diversity Leadership Team and providing strategic direction for the company’s overall diversity and inclusion efforts. In February of 2010, Harris was honored with the prestigious Black Engineer of the Year Award.

Mr. Harris received his Bachelor of Science degree in Business Administration from Boston University.

Michael D. Capellas, Chairman of the Flex Board, said, “John brings a proven track record of success developing and managing global businesses. He will be a valuable addition to the team and we are proud to have him on the board.”

About Flex

Flex (Reg. No. 199002645H) is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets.For more information, visit flex.com.

Media & Press

Silvia Gianelli

Senior Director, Corporate Communications

(408) 797-7130

[email protected]

Investors & Analysts

David Rubin

Vice President, Investor Relations

(408) 577-4632

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Technology Engineering Transport Telecommunications Manufacturing Software Internet Hardware Logistics/Supply Chain Management

MEDIA:

Logo
Logo

The Manitowoc Company to Present at Credit Suisse 8th Annual Virtual Industrials Conference on Thursday, December 3, 2020

The Manitowoc Company to Present at Credit Suisse 8th Annual Virtual Industrials Conference on Thursday, December 3, 2020

MILWAUKEE–(BUSINESS WIRE)–
The Manitowoc Company, Inc. (NYSE: MTW) announced that President and Chief Executive Officer Aaron H. Ravenscroft and Executive Vice President and Chief Financial Officer David J. Antoniuk will participate in a fireside chat at the Credit Suisse 8th Annual Virtual Industrials Conference on Thursday, December 3, 2020.

The fireside chat is scheduled from 10:10 to 10:40 a.m. ET. A link to the live audio webcast of the presentation and presentation materials can be accessed from Manitowoc’s Investor Relations website ahead of the event at http://ir.manitowoc.com. The webcast will be available for replay at the same link.

About The Manitowoc Company, Inc.

The Manitowoc Company, Inc. (“Manitowoc”) was founded in 1902 and has over a 117-year tradition of providing high-quality, customer-focused products and support services to its markets, and its 2019 net sales were approximately $1.83 billion. Manitowoc is one of the world’s leading providers of engineered lifting solutions. Manitowoc, through its wholly-owned subsidiaries, designs, manufactures, markets, and supports comprehensive product lines of mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks under the Grove, Manitowoc, National Crane, Potain, Shuttlelift and Manitowoc Crane Care brand names.

Ion Warner

Vice President, Marketing and Investor Relations

+1 414-760-4805

KEYWORDS: Wisconsin United States North America

INDUSTRY KEYWORDS: Engineering Other Construction & Property Residential Building & Real Estate Manufacturing Commercial Building & Real Estate Construction & Property Other Manufacturing

MEDIA:

Logo
Logo

Forte Biosciences, Inc. to Present at the Evercore ISI 3rd Annual HealthCONx Conference on December 3rd

Forte Biosciences, Inc. to Present at the Evercore ISI 3rd Annual HealthCONx Conference on December 3rd

TORRANCE, Calif.–(BUSINESS WIRE)–
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today announced that Paul Wagner, Ph.D., CEO of Forte Biosciences will be presenting at the Evercore ISI Annual HealthCONx Conference on December 3, 2020.

Webcast Information

Forte management will host a webcast on Thursday December 3rd, 2020 at 11:20 AM Eastern Time. Participants may access the webcast through the following link:

https://wsw.com/webcast/evercore11/fbrx/2363658

The webcast can also be accessed from the investor relations section of Forte’s website at https://www.fortebiorx.com. A replay of the webcast will also be available through December 10th through the above link.

About Forte

Forte Biosciences, Inc. is a clinical stage, dermatology company developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric (3 years of age and older) patients with atopic dermatitis. There is a significant unmet need for safe and effective therapies particularly for pediatric atopic dermatitis patients. In September 2020, Forte initiated a multi-center, placebo controlled clinical trial of FB-401 which is expected to enroll pediatric, adolescent and adult AD subjects aged 2 years of age and older. For additional information about the trial, see ClinicalTrials.gov using the identifier NCT04504279.

Forward Looking Statements

Forte cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negatives of these terms or other similar expressions. These statements are based on the company’s current beliefs and expectations. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation: risks related to Forte’s ability to obtain sufficient additional capital to continue to advance Forte’s product candidates and preclinical programs; uncertainties associated with the clinical development and regulatory approval of Forte’s product candidates, including potential delays in the commencement, enrollment and completion of clinical trials; the risk that interim results of clinical trials do not necessarily predict final results and that one or more of the clinical outcomes may materially change as patient enrollment continues, following more comprehensive reviews of the data, and as more patient data become available; the risk that unforeseen adverse reactions or side effects may occur in the course of developing and testing product candidates; risks associated with the failure to realize any value from product candidates and preclinical programs being developed and anticipated to be developed in light of inherent risks and difficulties involved in successfully bringing product candidates to market; and risks related to the impact of the COVID-19 outbreak on Forte’s operations, the biotechnology industry and the economy generally. Information on these and additional risks, uncertainties, and other information affecting Forte’s business and operating results is contained in Forte’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the Securities and Exchange Commission on November 9, 2020 and in its other filings with the Securities and Exchange Commission. All forward-looking statements in this press release are current only as of the date hereof and, except as required by applicable law, Forte undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Source: Forte Biosciences, Inc.

Forte Biosciences, Inc.

Paul Wagner, CEO

[email protected]

LifeSci Advisors

Mike Moyer, Managing Director

617.308.4306

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health Clinical Trials

MEDIA:

Revance to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

Revance to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

NEWARK, Calif.–(BUSINESS WIRE)–
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company’s President and Chief Executive Officer, Mark Foley, will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference.

The fireside chat will be available online beginning December 1 in the investor relations section of the company’s website at www.revance.com. The virtual conference will be held from December 1-3, 2020.

About Revance Therapeutics, Inc.

Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection. DaxibotulinumtoxinA for Injection combines a proprietary stabilizing peptide excipient with a highly purified botulinum toxin that does not contain human or animal-based components. Revance has successfully completed a Phase 3 program for DaxibotulinumtoxinA for Injection in glabellar (frown) lines and is pursuing U.S. regulatory approval in 2020. Revance is also evaluating DaxibotulinumtoxinA for Injection in the full upper face, including glabellar lines, forehead lines and crow’s feet, as well as in two therapeutic indications – cervical dystonia and adult upper limb spasticity. To accompany DaxibotulinumtoxinA for Injection, Revance has built a unique portfolio of premium products and services for U.S. aesthetics practices, including the RHA® Collection of dermal fillers in the U.S., the first and only range of FDA-approved fillers for correction of dynamic facial wrinkles and folds, and the HintMD fintech platform, which includes integrated smart payment, subscription and loyalty digital services. Revance has also partnered with Viatris (formerly Mylan N.V.) to develop a biosimilar to BOTOX®, which would compete in the existing short-acting neuromodulator marketplace. Revance is dedicated to making a difference by transforming patient experiences. For more information or to join our team visit us at www.revance.com.

“Revance Therapeutics” and the Revance logo are registered trademarks of Revance Therapeutics, Inc.

RHA resilient hyaluronic acid® and RHA® are trademarks of TEOXANE SA.

BOTOX® is a registered trademark of Allergan, Inc.

Investors

Revance Therapeutics, Inc.:

Jeanie Herbert, 714-325-3584

[email protected]

or

Gilmartin Group, LLC.:

Laurence Watts, 619-916-7620

[email protected]

Media

Revance Therapeutics, Inc.:

Sara Fahy, 949-887-4476

[email protected]

or

General Media:

Y&R:

Jenifer Slaw, 347-971-0906

[email protected]

or

Trade Media:

Nadine Tosk, 504-453-8344

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Biotechnology General Health Pharmaceutical Health

MEDIA:

Western Union to Present at the Wells Fargo TMT Summit on December 1

Western Union to Present at the Wells Fargo TMT Summit on December 1

DENVER–(BUSINESS WIRE)–
The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today announced that the Company will present at the Wells Fargo TMT Summit on Tuesday, December 1, 2020. The presentation will begin at 6:00 p.m. Eastern time and will include comments from Raj Agrawal, CFO, and Shelly Swanback, President, Product and Platform.

Investors and interested parties will be able to listen to the investor presentation via webcast from http://www.westernunion.com, under the investor relations section. The archived webcast will be available shortly after the conclusion of the presentation.

About Western Union

The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Our omnichannel platform connects the digital and physical worlds and makes it possible for consumers and businesses to send and receive money and make payments with speed, ease, and reliability. As of September 30, 2020, our network included over 550,000 retail agent locations offering our branded services in more than 200 countries and territories, with the capability to send money to billions of accounts. Additionally, westernunion.com, our fastest growing channel in 2019, is available in over 75 countries, plus additional territories, to move money around the world. With our global reach, Western Union moves money for better, connecting family, friends, and businesses to enable financial inclusion and support economic growth. For more information, visit www.westernunion.com.

WU-G

Media Relations:

Pia De Lima

+1 (954) 260-5732

[email protected]

Investor Relations:

Brendan Metrano

+1 (720) 332-8089

[email protected]

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

IAA, Inc. Announces Participation in the Truist Securities 2020 Industrials & Services Summit

IAA, Inc. Announces Participation in the Truist Securities 2020 Industrials & Services Summit

WESTCHESTER, Ill.–(BUSINESS WIRE)–
IAA, Inc. (NYSE: IAA) today announced that the Company is scheduled to present at the Truist Securities 2020 Industrials & Services Summit on Tuesday, December 8, 2020, at 3:00 pm Eastern Time.

The audio portion of the presentation will be webcast live over the internet and can be accessed on the Company’s Investor Relations website, https://www.iaai.com/. An online archive will be available on that site following the presentation.

About IAA

IAA, Inc. (NYSE: IAA) is a leading global marketplace connecting vehicle buyers and sellers. Leveraging leading-edge technology and focusing on innovation, IAA’s unique platform facilitates the marketing and sale of total-loss, damaged and low-value vehicles. Headquartered near Chicago in Westchester, Illinois, IAA has nearly 4,000 employees and more than 200 facilities throughout the U.S., Canada and the United Kingdom. IAA serves a global buyer base – located throughout over 170 countries – and a full spectrum of sellers, including insurers, dealerships, fleet lease and rental car companies, and charitable organizations. Buyers have access to multiple digital bidding and buying channels, innovative vehicle merchandising, and efficient evaluation services, enhancing the overall purchasing experience. IAA offers sellers a comprehensive suite of services aimed at maximizing vehicle value, reducing administrative costs, shortening selling cycle time and delivering the highest economic returns. For more information, visit IAAI.com and follow IAA on Facebook, Twitter, Instagram, YouTube and LinkedIn.

Media Inquiries:

Jeanene O’Brien

SVP Global Marketing & Communications

(312) 622-4068

[email protected]

Investor Inquiries:

Farah Soi/Caitlin Churchill

ICR

(203) 682-8200

[email protected]

Arif Ahmed

Vice President, Treasury

(708) 492-7257

[email protected]

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: General Automotive Other Automotive Automotive

MEDIA:

Griffon to Participate at the Bank of America 2020 Leveraged Finance Conference

Griffon to Participate at the Bank of America 2020 Leveraged Finance Conference

NEW YORK–(BUSINESS WIRE)–
Griffon Corporation (“Griffon” or the “Company”) (NYSE:GFF) today announced it will present at the Bank of America 2020 Leveraged Finance Conference on Tuesday, December 1, 2020. The conference will be held in a virtual format. A copy of Griffon’s investor presentation, which will be used for the conference, will be available at the time of the conference in the investor relations section of Griffon’s website (www.griffon.com).

About Griffon Corporation

Griffon is a diversified management and holding company that conducts business through wholly-owned subsidiaries. Griffon oversees the operations of its subsidiaries, allocates resources among them and manages their capital structures. Griffon provides direction and assistance to its subsidiaries in connection with acquisition and growth opportunities as well as in connection with divestitures. In order to further diversify, Griffon also seeks out, evaluates and, when appropriate, will acquire additional businesses that offer potentially attractive returns on capital.

Griffon conducts its operations through three reportable segments:

  • Consumer and Professional Products (“CPP”) conducts its operations through The AMES Companies, Inc. (“AMES”). Founded in 1774, AMES is the leading North American manufacturer and a global provider of branded consumer and professional tools and products for home storage and organization, landscaping, and enhancing outdoor lifestyles. CPP sells products globally through a portfolio of leading brands including True Temper, AMES, and ClosetMaid.
  • Home and Building Products conducts its operations through Clopay Corporation (“Clopay”). Founded in 1964, Clopay is the largest manufacturer and marketer of garage doors and rolling steel doors in North America. Residential and commercial sectional garage doors are sold through professional dealers and leading home center retail chains throughout North America under the brands Clopay, Ideal, and Holmes. Rolling steel door and grille products designed for commercial, industrial, institutional, and retail use are sold under the CornellCookson brand.
  • Defense Electronics conducts its operations through Telephonics Corporation, founded in 1933, a globally recognized leading provider of highly sophisticated intelligence, surveillance and communications solutions for defense, aerospace and commercial customers.

For more information on Griffon and its operating subsidiaries, please see the Company’s website at www.griffon.com.

Company:

Brian G. Harris

SVP & Chief Financial Officer

Griffon Corporation

(212) 957-5000

Investor Relations:

Michael Callahan

Managing Director

ICR Inc.

(203) 682-8311

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA: